News and resources

Media Release: Victorian Cancer Biobank marks 20 years of driving cancer breakthroughs

Monday 22 June 2026

The Victorian Cancer Biobank is marking 20 years at the forefront of cancer research – a milestone that underscores its role as one of Australia’s most powerful engines for life-saving discovery.

Response to the Issue Paper - Australian Law Reform Commission’s Review of Human Tissue Laws

Friday 29 August 2025

The Victorian Cancer Biobank (VCB) has submitted a comprehensive response to the Australian Law Reform Commission’s review of Human Tissue Laws (HTA), advocating for reforms that better support ethical, equitable, and impactful research.

Release of VCB Key Achievements 2023-24 FY

Wednesday 25 June 2025

We are pleased to present our key achievements and impact for the 2023–24 financial year, highlighting the progress, contributions, and outcomes delivered through our biobanking efforts in support of cancer research.

ISBER 2024 Annual Meeting in Melbourne, Australia

Friday 22 September 2023

The ISBER annual meeting has been the premier event in biobanking education for over 20 years and is the only truly global event in biobanking.

Biobanking Panel Discussion

In Australia, we have a high-quality, active biobanking community that supports a wide range of research. The 2021 National Research Infrastructure Roadmap acknowledged the strength of the Australian biobanking ecosystem but highlighted the need for enhanced coordination to maximize the impact of our biobanks. In this session, we are honoured to welcome Prof. Jens Habermann, Director-General of BBMRI-ERIC, to share insights on BBMRI-ERIC's structure and outcomes. Additionally, a brief overview o...

Basic Science research to discover potential cancer biomarker

Wednesday 21 December 2022

A new protein involved in breast cancer has been revealed by Dr Jeremy Drake (Victoria University) and a group of Australian and international collaborators.

Novel self-test for cancer monitoring - Tn Antigen 'blood prick' test

Wednesday 21 December 2022

Universal Biosensors, a Victorian based company, has obtained biospecimens from VCB for their international development clinical study. Their study aims to develop a handheld portable cancer biosensor for T and Tn Antigen using a “finger prick” blood test for measuring patient cancer remission and reoccurrence.

Supporting Bench to Bed Discovery – the Story of SubB2

Friday 10 December 2021

Professor Michael Jennings and his laboratory at Griffith University’s Institute of Glycomics, along with collaborators Prof James Patton and Prof A Patton at the University of Adelaide, have developed a novel technology for the early detection of various cancers including ovarian and breast cancer.

Latest news View all